Patriot Coal (NYSE: PCX), Petrohawk Energy (NYSE: HK), DeVry Inc. (NYSE: DV), AngioDynamics (NASDAQ: ANGO) and Pharmaceutical Product Development (NASDAQ: PPDI) upgraded by analysts.
Canaccord Genuity upgraded AngioDynamics (ANGO) from a “Hold” rating to a “Buy” rating. They have a price target of $16.50 on the company, up from $15.00.
UBS AG (NYSE: UBS) upgraded DeVry Inc. (DV) from a “Neutral” rating to a “Buy” rating. They have a price target of $75.00 on the company, up from $55.00.
Lazard Capital upgraded Petrohawk Energy (HK) was upgraded by analysts at from a “Sell” rating to a “Neutral” rating.
BMO Capital Markets upgraded Patriot Coal (PCX) to a “Market Perform” rating.
William Blair upgraded Pharmaceutical Product Development (PPDI) from a “Market Perform” rating to an “Outperform” Rating.
Shitty useless post
ReplyDelete